Kathleen A. Farley - Concepedia

Author

Kathleen A. Farley

Also Known As

Farley, Kathleen, Farley, Kathleen A., K. A. FARLEY, K. A. Farley, Kathleen A Farley, Kathleen A. Farley, Kathleen Farley

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Foton Motors (China)Utah State University University of California, Santa Cruz Carnegie Mellon University

About

Kathleen A. Farley is an author at Pfizer (United States) specializing in biochemistry, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	718
2	Biochemistry	13	13	384
3	Natural Sciences	12	12	855
4	Engineering	7	7	540
5	Health Sciences	2	2	229

Kathleen A. Farley

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Delineating the role of cooperativity in the design of potent PROTACs for BTK Adelajda Zorba, Chuong Nguyen, Yingrong Xu, Proceedings of the National Academy of Sciences EngineeringMolecular BiologyOrganic ChemistryChemistrySignaling Pathway	2018	409
A New Resistance Gene, <i>linB</i> , Conferring Resistance to Lincosamides by Nucleotidylation in <i>Enterococcus faecium</i> HM1025 Bülent Bozdoğan, Latifa Berrezouga, M. S. KUO, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeBacteriologyMolecular BiologyPathologyEscherichia Coli	1999	175
Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance Arthur C Rand, Siegfried S. F. Leung, Heather Eng, MedChemComm	2012	131
Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications Andreas Maderna, Matthew Doroski, Chakrapani Subramanyam, Journal of Medicinal Chemistry NanotherapeuticsLead AuristatinPeptide ScienceChemical BiologyPharmaceutical Chemistry	2014	130
Integrating Intramolecular Hydrogen Bonding (IMHB) Considerations in Drug Discovery Using ΔlogP As a Tool Marina Shalaeva, Giulia Caron, Yuriy A. Abramov, Journal of Medicinal Chemistry Reliable δLogpDrug TargetComputational δLogpSystems PharmacologyMolecular Pharmacology	2013	85
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19 Charlotte Allerton, Joel T. Arcari, Lisa Aschenbrenner, Journal of Medicinal Chemistry	2024	59
Discovery of Azetidinyl Ketolides for the Treatment of Susceptible and Multidrug Resistant Community-Acquired Respiratory Tract Infections Thomas V. Magee, Sharon L. Ripp, Bryan Li, Journal of Medicinal Chemistry Health SciencesAntibioticsMedicineKlebsiella PneumoniaeMacrolides Addresses Resistance	2009	54
A New and Useful Method for the Macrocyclization of Linear Peptides Allyn T. Londregan, Kathleen A. Farley, Chris Limberakis, Organic Letters Bioorganic ChemistryPeptide EngineeringPeptide SciencePeptide ChemistryMedicinal Chemistry	2012	52
Non-Uniform Sampling for All: More NMR Spectral Quality, Less Measurement Time. Frank Delaglio, Gregory S. Walker, Kathleen A. Farley, PubMed Sampling (Signal Processing)MeasurementMagnetic Resonance SpectroscopySpectroscopyResonance	2017	46
Comparative pharmacokinetic profile of cyclosporine (CsA) with a decapeptide and a linear analogue David A. Price, Heather Eng, Kathleen A. Farley, Organic & Biomolecular Chemistry	2017	33

Page 1